Drug Database
J01FF01 clindamycin
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Clindamycin 150 mg Capsules
- POM Clindamycin 150 mg Capsules, Hard
- POM Clindamycin 150 mg hard capsules
- POM Clindamycin 150mg Capsules
- POM Clindamycin 150mg Hard Capsules
- POM Clindamycin 150mg/ml Solution for Injection or Infusion
- POM Clindamycin 300 mg Capsules
- POM Clindamycin 300 mg Capsules, Hard
- POM Clindamycin 300 mg hard capsules
- POM Clindamycin 300 mg/50 ml solution for infusion
- POM Clindamycin 300mg/2ml solution for injection ampoules (150mg/ml in 2ml ampoules)
- POM Clindamycin 600 mg/50 ml solution for infusion
- POM Clindamycin 600mg/4ml solution for injection ampoules (150mg/ml in 4 ml ampoules)
- POM Clindamycin 75 mg Capsules, Hard
- POM Dalacin C Capsules 150 mg
- POM Dalacin C Capsules 75mg
- POM Dalacin C Phosphate Sterile Solution, Clindamycin 150 mg/ml Solution for Injection
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).